The invention generally relates to monoclonal antibodies that recognize at least one compound from the group consisting of (+) methamphetamine, (+) amphetamine, and (+) 3,4-methylenedioxymethamphetamine ((+) MDMA). Generally speaking, the monoclonal antibodies do not recognize (-) methamphetamine, (-) amphetamine, or (-) MDMA.
US7858756; EP2032602 (B1); ES2415655 (T3)
Board of Trustees of the University of Arkansas (Little Rock, AR)
Owens, S. Michael; Gunnell, Melinda; Chi, Yingni; Carroll, F. Ivy; Henry, Ralph; and Peterson, Eric, "Monoclonal antibodies that selectively recognize methamphetamine and methamphetamine like compounds" (2010). Patents Granted. 75.